POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY

Autor: AHMAD, S., Bhasin, N., Sinha, S., Sayed, S.A., Bansode, J., Swami, R., Mehta, K.
Zdroj: In Kidney International Reports April 2021 6(4) Supplement:S203-S203
Databáze: ScienceDirect